390 related articles for article (PubMed ID: 27170456)
1. Development and Pharmacological Evaluation of New Bone-Targeted (99m)Tc-Radiolabeled Bisphosphonates.
Makris G; Tseligka ED; Pirmettis I; Papadopoulos MS; Vizirianakis IS; Papagiannopoulou D
Mol Pharm; 2016 Jul; 13(7):2301-17. PubMed ID: 27170456
[TBL] [Abstract][Full Text] [Related]
2. NOTA and NODAGA [
Makris G; Radford LL; Kuchuk M; Gallazzi F; Jurisson SS; Smith CJ; Hennkens HM
Bioconjug Chem; 2018 Dec; 29(12):4040-4049. PubMed ID: 30412382
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of Re/
Radford LL; Papagiannopoulou D; Gallazzi F; Berendzen A; Watkinson L; Carmack T; Lewis MR; Jurisson SS; Hennkens HM
Bioorg Med Chem; 2019 Feb; 27(3):492-501. PubMed ID: 30594453
[TBL] [Abstract][Full Text] [Related]
4. 99mTc(CO)3-labeled pamidronate and alendronate for bone imaging.
Palma E; Correia JD; Oliveira BL; Gano L; Santos IC; Santos I
Dalton Trans; 2011 Mar; 40(12):2787-96. PubMed ID: 21301703
[TBL] [Abstract][Full Text] [Related]
5. Mixed tridentate π -donor and monodentate π -acceptor ligands as chelating systems for rhenium-188 and technetium-99m nitrido radiopharmaceuticals.
Boschi A; Uccelli L; Pasquali M; Pasqualini R; Guerrini R; Duatti A
Curr Radiopharm; 2013 Sep; 6(3):137-45. PubMed ID: 24106999
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m and rhenium-188 complexes with one and two pendant bisphosphonate groups for imaging arterial calcification.
Bordoloi JK; Berry D; Khan IU; Sunassee K; de Rosales RT; Shanahan C; Blower PJ
Dalton Trans; 2015 Mar; 44(11):4963-75. PubMed ID: 25559039
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in vivo biological investigations on a novel radioligand for bone scanning: technetium-99m-labeled zoledronic acid derivative.
Lin J; Qiu L; Cheng W; Luo S; Ye W
Nucl Med Biol; 2011 Jul; 38(5):619-29. PubMed ID: 21718936
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of novel (99m)Tc-labelled bisphosphonates as superior bone imaging agents.
Qiu L; Cheng W; Lin J; Luo S; Xue L; Pan J
Molecules; 2011 Jul; 16(8):6165-78. PubMed ID: 21788926
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization, and biological evaluation of new biotinylated (99m) Tc/Re-tricarbonyl complexes.
Makris G; Papagiannopoulou D
J Labelled Comp Radiopharm; 2016 Mar; 59(3):95-102. PubMed ID: 26817576
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin receptor targeting with hydrophilic [
Makris G; Kuchuk M; Gallazzi F; Jurisson SS; Smith CJ; Hennkens HM
Nucl Med Biol; 2019 Apr; 71():39-46. PubMed ID: 31129499
[TBL] [Abstract][Full Text] [Related]
11. Development and Preclinical Evaluation of
Makris G; Bandari RP; Kuchuk M; Jurisson SS; Smith CJ; Hennkens HM
Mol Imaging Biol; 2021 Feb; 23(1):52-61. PubMed ID: 32886303
[TBL] [Abstract][Full Text] [Related]
12. Microwave-assisted synthesis of organometallic complexes of ⁹⁹mTc(CO)₃ and Re(CO)₃: its application to radiopharmaceuticals.
Kimura H; Mori D; Harada N; Ono M; Ohmomo Y; Kajimoto T; Kawashima H; Saji H
Chem Pharm Bull (Tokyo); 2012; 60(1):79-85. PubMed ID: 22223378
[TBL] [Abstract][Full Text] [Related]
13. Coordination modes of multidentate ligands in fac-[Re(CO)(3)(polyaminocarboxylate)] analogues of (99m)Tc radiopharmaceuticals. dependence on aqueous solution reaction conditions.
Lipowska M; He H; Xu X; Taylor AT; Marzilli PA; Marzilli LG
Inorg Chem; 2010 Apr; 49(7):3141-51. PubMed ID: 20201565
[TBL] [Abstract][Full Text] [Related]
14. Development of superior bone scintigraphic agent from a series of (99m)Tc-labeled zoledronic acid derivatives.
Lin J; Qiu L; Cheng W; Luo S; Xue L; Zhang S
Appl Radiat Isot; 2012 May; 70(5):848-55. PubMed ID: 22381699
[TBL] [Abstract][Full Text] [Related]
15. A new bisphosphonate-containing (99m)Tc(I) tricarbonyl complex potentially useful as bone-seeking agent: synthesis and biological evaluation.
Palma E; Oliveira BL; Correia JD; Gano L; Maria L; Santos IC; Santos I
J Biol Inorg Chem; 2007 Jun; 12(5):667-79. PubMed ID: 17333301
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Rhenium and Technetium-99m Complexes Bearing Quinazoline Derivatives as Potential EGFR Agents.
Makrypidi K; Kiritsis C; Roupa I; Triantopoulou S; Shegani A; Paravatou-Petsotas M; Chiotellis A; Pelecanou M; Papadopoulos M; Pirmettis I
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838773
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of new mixed "2 + 1" Re,
Shegani A; Ischyropoulou M; Roupa I; Kiritsis C; Makrypidi K; Papasavva A; Raptopoulou C; Psycharis V; Hennkens HM; Pelecanou M; Papadopoulos MS; Pirmettis I
Bioorg Med Chem; 2021 Oct; 47():116373. PubMed ID: 34467870
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and SAR of ⁹⁹mTc/Re-labeled small molecule prostate specific membrane antigen inhibitors with novel polar chelates.
Lu G; Maresca KP; Hillier SM; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
Bioorg Med Chem Lett; 2013 Mar; 23(5):1557-63. PubMed ID: 23333070
[TBL] [Abstract][Full Text] [Related]
19. Isothiocyanate-Functionalized Bifunctional Chelates and fac-[M(I)(CO)3](+) (M = Re, (99m)Tc) Complexes for Targeting uPAR in Prostate Cancer.
Kasten BB; Ma X; Cheng K; Bu L; Slocumb WS; Hayes TR; Trabue S; Cheng Z; Benny PD
Bioconjug Chem; 2016 Jan; 27(1):130-42. PubMed ID: 26603218
[TBL] [Abstract][Full Text] [Related]
20. Chemical and biological characterization of technetium(I) and Rhenium(I) tricarbonyl complexes with dithioether ligands serving as linkers for coupling the Tc(CO)(3) and Re(CO)(3) moieties to biologically active molecules.
Pietzsch HJ; Gupta A; Reisgys M; Drews A; Seifert S; Syhre R; Spies H; Alberto R; Abram U; Schubiger PA; Johannsen B
Bioconjug Chem; 2000; 11(3):414-24. PubMed ID: 10821659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
